Type 2 Diabetes Key Messages


Click to view key message slide set

Metformin should be used as a first-line medication in almost every patient with type 2 diabetes.


Click to view key message slide set

DPP-4 inhibitors and GLP-1 agonists should not be used first line in patients with type 2 diabetes because metformin, sulfonylureas and insulin are more efficacious.


Click to view key message slide set

HbA1C goals should be individualized for each patient with type 2 diabetes: less than 7% for most patients and less than 8% for specific high-risk subgroups. Patients with type 2 diabetes should have an HbA1C test every three to six months.